Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study


Cutland C. L. , Nolan T., Halperin S. A. , Kurugol Z. A. , Ahmed K., Perrett K. P. , ...Daha Fazla

VACCINE, cilt.36, sa.14, ss.1908-1916, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Konu: 14
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.vaccine.2018.02.013
  • Dergi Adı: VACCINE
  • Sayfa Sayıları: ss.1908-1916

Özet

Background: We evaluated the immunogenicity and safety of 1 and 2 doses of quadrivalent meningococcal serogroup A, C, W and Y tetanus toxoid-conjugate vaccine (MenACWY-IT) given alone or co administered with 13-valent pneumococcal conjugate vaccine (PCV13) in toddlers.